Drugs / Irinotecan liposome injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06210360 | Feb 2024 → Apr 2025 overdue | malignant pancreatic neoplasm | Changhai Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Irinotecan liposome injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06210360 ↗ |